AGL 38.00 Decreased By ▼ -0.25 (-0.65%)
AIRLINK 136.45 Decreased By ▼ -2.52 (-1.81%)
BOP 5.44 Decreased By ▼ -0.01 (-0.18%)
CNERGY 3.80 Increased By ▲ 0.01 (0.26%)
DCL 7.50 Decreased By ▼ -0.07 (-0.92%)
DFML 45.41 Decreased By ▼ -0.74 (-1.6%)
DGKC 78.52 Increased By ▲ 0.41 (0.52%)
FCCL 28.89 Decreased By ▼ -0.21 (-0.72%)
FFBL 57.00 Decreased By ▼ -0.10 (-0.18%)
FFL 9.27 Increased By ▲ 0.57 (6.55%)
HUBC 96.80 Decreased By ▼ -5.02 (-4.93%)
HUMNL 13.40 Decreased By ▼ -0.85 (-5.96%)
KEL 3.77 Decreased By ▼ -0.05 (-1.31%)
KOSM 7.28 Decreased By ▼ -0.12 (-1.62%)
MLCF 37.80 Decreased By ▼ -0.55 (-1.43%)
NBP 67.50 Decreased By ▼ -2.00 (-2.88%)
OGDC 167.52 Decreased By ▼ -2.50 (-1.47%)
PAEL 25.10 Decreased By ▼ -0.55 (-2.14%)
PIBTL 6.70 Increased By ▲ 0.10 (1.52%)
PPL 131.50 Decreased By ▼ -2.08 (-1.56%)
PRL 26.40 Increased By ▲ 1.40 (5.6%)
PTC 15.10 Decreased By ▼ -0.44 (-2.83%)
SEARL 62.25 Decreased By ▼ -1.58 (-2.48%)
TELE 7.00 Increased By ▲ 0.05 (0.72%)
TOMCL 36.23 Decreased By ▼ -0.75 (-2.03%)
TPLP 7.88 Increased By ▲ 0.18 (2.34%)
TREET 14.00 Increased By ▲ 0.04 (0.29%)
TRG 44.55 Decreased By ▼ -0.42 (-0.93%)
UNITY 25.85 Increased By ▲ 0.45 (1.77%)
WTL 1.22 No Change ▼ 0.00 (0%)
BR100 9,143 Decreased By -61.6 (-0.67%)
BR30 27,326 Decreased By -391.2 (-1.41%)
KSE100 85,585 Decreased By -620.2 (-0.72%)
KSE30 26,984 Decreased By -252.2 (-0.93%)
Business & Finance

Moderna sees $18.4bn in sales from COVID-19 vaccine in 2021

  • Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.
  • Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.
Published February 25, 2021

Moderna Inc said on Thursday it was expecting to post $18.4 billion in sales from its COVID-19 vaccine this year.

Pfizer Inc, which makes the only other vaccine authorized for emergency use in the United States so far, said earlier this month that it was expecting to record sales of about $15 billion in 2021 from the coronavirus vaccine that it makes with German partner BioNTech.

Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.

Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.

Comments

Comments are closed.